Alpharetta, GA, United States of America

Mark A Lockwood



 

Average Co-Inventor Count = 6.3

ph-index = 4

Forward Citations = 36(Granted Patents)


Location History:

  • Portola Valley, CA (US) (1988)
  • Alpharetta, GA (US) (2007 - 2016)

Company Filing History:


Years Active: 1988-2016

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Mark A Lockwood: Innovator in Chemokine Receptor Modulators

Introduction

Mark A Lockwood is a notable inventor based in Alpharetta, GA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of chemokine receptor modulators. With a total of five patents to his name, Lockwood's work has the potential to impact the treatment of serious health conditions.

Latest Patents

Lockwood's latest patents focus on chemokine receptor modulators. These inventions provide compounds of Formula (I) and pharmaceutically acceptable salts, solvates, tautomers, stereoisomers, and/or esters thereof. The compounds and pharmaceutical compositions comprising such compounds are useful in treating or preventing HIV infections and in treating proliferative disorders, such as inhibiting the metastasis of various cancers.

Career Highlights

Throughout his career, Lockwood has worked with various organizations, including Altiris Therapeutics, Inc. His innovative approach and dedication to research have led to advancements in the pharmaceutical industry.

Collaborations

Lockwood has collaborated with notable individuals in his field, including Michael G Natchus and Michael P Clark. These partnerships have contributed to the development of his groundbreaking inventions.

Conclusion

Mark A Lockwood is a distinguished inventor whose work in chemokine receptor modulators holds promise for the treatment of HIV and cancer. His contributions to the field of pharmaceuticals are noteworthy and continue to influence medical research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…